Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

3.2%

11 terminated/withdrawn out of 339 trials

Success Rate

94.2%

+7.7% vs industry average

Late-Stage Pipeline

17%

56 trials in Phase 3/4

Results Transparency

9%

16 of 179 completed trials have results

Key Signals

44 recruiting16 with results6 terminated5 withdrawn

Enrollment Performance

Analytics

N/A
135(61.9%)
Phase 4
46(21.1%)
Phase 2
14(6.4%)
Phase 1
12(5.5%)
Phase 3
10(4.6%)
Early Phase 1
1(0.5%)
218Total
N/A(135)
Phase 4(46)
Phase 2(14)
Phase 1(12)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (339)

Showing 20 of 339 trials
NCT07721948Not ApplicableNot Yet Recruiting

Assessment of Catheter Tissue Contact in PFA

Role: lead

NCT07724028Not ApplicableEnrolling By Invitation

Neurovascular Bundle Stimulation During Robot-Assisted Radical Prostatectomy

Role: lead

NCT07665710Recruiting

Prediction of Pancreatogenic Diabetes After Partial Resection of the Pancreas

Role: lead

NCT07703098Phase 4Not Yet Recruiting

Hydrocortisone Versus Methylprednisolone for the Treatment of Glucocorticoid-Induced Adrenal Insufficiency

Role: lead

NCT06893211Phase 2Completed

Effect of Tirzepatide on Brown Adipose Tissue in Obesity

Role: lead

NCT07684846Not ApplicableCompleted

Longitudinal Plasma Proteomic Remodeling in Ovarian Cancer

Role: lead

NCT05336760Recruiting

Dysphagia, QoL and Attitudes Towards PEG in ALS Patients

Role: collaborator

NCT07581808Phase 4Recruiting

Dual PCSK9 Inhibition With Inclisiran and Alirocumab in Secondary Prevention

Role: lead

NCT07618858Not ApplicableNot Yet Recruiting

Comparison of Citrate and Heparin Anticoagulation During Postdilution Hemodiafiltration

Role: lead

NCT07604467Recruiting

The Role of CD34+ Stem Cells in the Pathogenesis of Takotsubo Syndrome

Role: lead

NCT07579962Phase 2Not Yet Recruiting

Treatment of Low-flow Vascular Malformations With Bleomycin Electrosclerotherapy (BEST)

Role: collaborator

NCT07599540Active Not Recruiting

Cardiovascular Risk in Peripheral Artery Disease Patients Undergoing Endovascular Revascularisation

Role: lead

NCT07584525Phase 3Recruiting

Dexamethasone in Tick-borne Encephalitis

Role: lead

NCT07134621Enrolling By Invitation

Target Organ Damage in Patients With Repaired Coarctation of Aorta and Exercise Induced Hypertension

Role: lead

NCT06613854Phase 4Recruiting

Effect of Early Combination Antihyperglycemic Treatment on Metabolic Control in Individuals With Type 2 Diabetes

Role: lead

NCT07496736Phase 3Active Not Recruiting

Post-exposure Influenza Prophylaxis in a Hospital Setting

Role: lead

NCT05607888Recruiting

Prospective Study of Sinonasal and Skull-base Tumours Management

Role: lead

NCT03337932Not ApplicableRecruiting

Duration of Doxycycline Treatment in MEM Patients

Role: lead

NCT03462329Not ApplicableRecruiting

Patient's Pretreatment Expectations About Post-Lyme Symptoms

Role: lead

NCT06023550Recruiting

Complicated Infections in Otorhinolaryngology

Role: lead